Gabapentin
- Product NDC
- 67296-1709
- 11-digit product format
- 672961709
- Labeler code
- 67296
- Product ID
- 67296-1709_b8dfb538-7988-5311-e053-2995a90a07bd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA206943
- Marketing category
- ANDA
- Marketing start
- 2018-05-14
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 67296-1709 | I | Inactivated by FDA | 2026-08-17 | ||
| excluded package | package | 67296-1709 | 67296-1709-3 | I | Inactivated by FDA | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 67296-1709-3 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 67296-1709-3 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 67296-1709-3 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 67296-1709-3 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 67296-1709-3 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 67296-1709-3 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 67296-1709-3 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 67296-1709-3 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 67296-1709-3 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 67296-1709-3 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 67296-1709-3 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 67296-1709-3 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 67296-1709-3 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 67296-1709-3 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 67296-1709-3 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206943-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | |
| A206943-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | |
| A206943-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206943-001 | AB |
| A206943-002 | AB |
| A206943-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206943-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | AB | 2018-05-14 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206943-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | AB | 2018-05-14 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206943-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | AB | 2018-05-14 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A206943-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A206943-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A206943-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A206943-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A206943-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A206943-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206943-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206943-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A206943-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A206943-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A206943-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A206943-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206943-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206943-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A206943-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206943-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206943-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A206943-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206943-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206943-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A206943-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206943-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206943-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A206943-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206943-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206943-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A206943-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206943-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206943-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A206943-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A206943-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A206943-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A206943-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206943-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206943-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A206943-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206943-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206943-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A206943-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A206943-001 | AB | 1 | 1e350fbaab3a… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cdc2ae60-922e-452d-a42f-787fe4e2ed06 | Product name | 1 | 20250123 |
| 7059096a-4b9f-36c2-db50-bb5c723e6e9e | Product name | 2 | 20250114 |
| fa3f0129-3502-889f-f424-3a37727959e7 | Product name | 9 | 20181206 |
| 77d89e4c-f57f-326d-d7aa-787f8eebbd2b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67296-1709-3 | 2023-01-30 | C162847 | 48780-1 | f386c649-e4be-0266-e053-dadaa90a7c1a | Gabapentin 100mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67296-1709-3 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67296-1709 | GABAPENTIN CAPSULE [REDPHARM DRUG, INC.] | 7 | Legacy NDC, 1 package rows | 20210115_96cb7daa-a57a-6b0b-e053-2995a90add23.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 57492b91-1fe2-74ab-e063-6394a90a0b9e | 2026-07-20 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 3c585b71-5cfc-18d6-e063-6294a90a3dcf | 2026-07-17 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 4ddcdff5-8f1f-bff3-e063-6294a90a1195 | 2026-07-07 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | f93eaa4f-cc1a-10ab-e053-6394a90a5ffc | 2026-06-02 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | St Mary's Medical Park Pharmacy | de990f96-96bc-406d-e053-2995a90abebb | 2026-05-01 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 6ecf5114-2ddc-4025-a36d-1884702dc22a | 2026-04-29 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | f396ec70-826d-45c6-a27c-343c2fac878c | 2026-04-29 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Strides Pharma Science Limited | 798575b9-ddfa-4915-9574-626abbaf025f | 2026-04-04 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 167d8b87-506c-4293-9579-563feaa71583 | 2025-07-30 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ca8177ed-1f0d-436e-a5ac-f58b8f7cbb25 | 2025-07-28 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Direct_Rx | f40a4ee4-ae8e-769c-e053-2a95a90a344e | 2025-01-22 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | ADVANCED RX OF TENNESSEE, LLC | af73fbd8-9731-e6bf-e053-2995a90af65d | 2024-12-31 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | fb0b6613-57d6-4e24-946f-f5f87c460cf0 | 2024-10-18 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ef37f2a0-3b83-4f71-91c0-6435161b483c | 2024-10-18 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 8e6ed5d2-40e0-1f06-e053-2a95a90aa40e | 2024-06-18 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | ed219efc-84e3-5bdc-e053-2a95a90a56fc | 2024-04-11 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 38210141-bbdc-4186-b71f-54c72f794dca | 2024-04-03 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 75418d32-6504-4cb4-b3a9-afa0eaf19b8d | 2024-04-03 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 1ec656c9-034f-4f14-9e6b-9779d41e1627 | 2024-04-03 | Warnings, Adverse reactions | 206943 ANDA206943 |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 8de89818-805a-4a20-a9b1-48cf443b6315 | 2024-04-03 | Warnings, Adverse reactions | 206943 ANDA206943 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310430 | gabapentin 100 MG Oral Capsule | PSN | 96cb7daa-a57a-6b0b-e053-2995a90add23 | 7 |
| 310430 | gabapentin 100 MG Oral Capsule | SCD | 96cb7daa-a57a-6b0b-e053-2995a90add23 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67296-1709-3 | 67296170903 | 30 CAPSULE in 1 BOTTLE (67296-1709-3) | 30 capsule | 2019-11-01 | 0000-00-00 | No | No | Current |